Trends

Report: Looking for the pharmaceutical-biotechnology alliance creates a win-win

Published in Cancer Weekly, December 30th, 2003

On November 24, 2003, Bristol-Myers Squibb and ImClone Systems announced that ImClone had filed for a new drug submission for Erbitux, a drug to aid the treatment of colorectal cancer.

This pharma-biotech alliance is just one of many that can create a win-win situation for both companies.

Pharma-biotech alliances are consistently succeeding more often than mergers and acquisitions, according to "Building Pharmaceutical-Biotechnical Partnerships," a report released by Durham, North Carolina-based business intelligence firm Cutting Edge Information.

The report explains that in the 1980s and 1990s businesses saw the fall of the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2003-12-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry